Trial Information

Summary: Social Anxiety Disorder Research Study
A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Forced Dose Titration Study Evaluating the Efficacy and Safety of GW679769 and Paroxetine in Subjects with Social Anxiety Disorder.

Social Anxiety Disorder (SAD, formerly called social phobia) is a serious illness affecting more than seven million individuals in the US and Canada. Individuals with social anxiety disorder experience extreme anxiety and fear of everyday social situations. Their anxiety can interfere with work, school, and daily life, [disrupting their lives/holding them back].

We are seeking adult ages 18-65 with social anxiety disorder (SAD) for participation in a clinical research study. The purpose of this research study is to evaluate the safety and effectiveness of an investigational medication for SAD.

Participation in this research study may include the following at no cost:

• Approximately 19 weeks of participation
• As many as 15 visits to a local physician's office
• Study-related examinations
• Study-related laboratory tests
• Study-related medication

Patient Inclusion Criteria = Social Anxiety
Patient Exclusion Criteria = Patients participating in regular strenuous exercise (greater than 5hrs per week running, weightlifting, etc)
Iron deficiency
Regular psychotherapy within past 12 weeks
Substance abuse
Aspirin or anti-inflammatory medications

If you would like to learn more about participating in this study, please send an e-mail message using the form below.